Management of hereditary angioedema in pediatric patients

Pediatrics

Volumn 120, Issue 3, 2007, Pages

  Farkas, Henriette ^a   Varga, Lilian ^a   Széplaki, Gábor ^a   Visy, Beáta ^b   Harmat, George ^b   Bowen, Tom ^c  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b HEIM PÁL CHILDREN S HOSPITAL   (Hungary)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

C1 inhibitor; Danazol; Hereditary angioedema; Pediatrics; Tranexamic acid

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; ANTIHISTAMINIC AGENT; BRADYKININ B2 RECEPTOR ANTAGONIST; COMPLEMENT COMPONENT C1S INHIBITOR; CORTICOSTEROID; DANAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DX 88; FRESH FROZEN PLASMA; ICATIBANT; KALLIKREIN INHIBITOR; STANOZOLOL; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

ANGIONEUROTIC EDEMA; CLINICAL FEATURE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DIAGNOSTIC PROCEDURE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDICATION; DRUG SAFETY; DRUG SUBSTITUTION; EDEMA; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEMATURIA; HIRSUTISM; HOME CARE; HUMAN; LABORATORY TEST; LIBIDO; MEDICAL EDUCATION; MEDICAL INFORMATION; MENSTRUAL IRREGULARITY; MUSCLE NECROSIS; MUSCLE WEAKNESS; MYALGIA; NEWBORN INTENSIVE CARE; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; PROPHYLAXIS; RARE DISEASE; RECURRENT DISEASE; RETINA DISEASE; REVIEW; RISK FACTOR; SIDE EFFECT; THROMBOSIS; TREATMENT CONTRAINDICATION; TREATMENT FAILURE; VIRILIZATION; WEIGHT GAIN;

ABDOMEN, ACUTE; ALGORITHMS; ANGIONEUROTIC EDEMA; CHILD; COMPLEMENT C1 INHIBITOR PROTEIN; COMPLEMENT C4; COMPLEMENT INACTIVATING AGENTS; EARLY DIAGNOSIS; EDEMA; HUMANS; LARYNGEAL EDEMA; SELF ADMINISTRATION; SUBCUTANEOUS TISSUE;

EID: 34548445562     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-3303     Document Type: Review

References (81)

1. Donaldson VH, Rosen FS. Hereditary angioneurotic edema: a clinical survey. Pediatrics. 1966;37:1017-1027
2. Rosen FS, Pensky J, Donaldson V, Charache P. Hereditary angioneurotic edema: two genetic variants. Science. 1965;148:957-958
3. Agostoni A, Aygoren-Pursun E, Binkley KE, et al. Hereditary and acquired angioedema: problems and progress - proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol. 2004;114(3 suppl):S51-S131
4. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angio-oedema. Lancet. 1998;351:1693-1697
5. Frank MM, Gelfand JA, Atkinson JP. Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med. 1976;84:580-593
6. Sim TC, Grant JA. Hereditary angioedema: its diagnostic and management perspectives. Am J Med. 1990;88:656-664
7. Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore). 1992;71:206-215
8. Carugati A, Pappalardo E, Zingale LC, Cicardi M. C1-inhibitor deficiency and angioedema. Mol Immunol. 2001;38:161-173
9. Farkas H, Harmat G, Fust G, Varga L, Visy B. Clinical management of hereditary angio-oedema in children. Pediatr Allergy Immunol. 2002;13:153-161
10. Gompels MM, Lock RJ, Abinun M, et al. C1 inhibitor deficiency: consensus document [published correction appears in Clin Exp Immunol. 2005;141:189-190]. Clin Exp Immunol. 2005;139:379-394
11. Roche O, Blanch A, Caballero T, Sastre N, Callejo D, Lopez-Trascasa M. Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. Ann Allergy Asthma Immunol. 2005;94:498-503
12. Zingale LC, Beltrami L, Zanichelli A, et al. Angioedema without urticaria: a large clinical survey. CMAJ. 2006;175:1065-1070
13. Bork K, Staubach P, Eckardt AJ, Hardt J. Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am J Gastroenterol. 2006;101:619-627
14. Blohmě G, Ysander L, Korsan-Bengtsen K, Laurell AB. Hereditary angioneurotic oedema in three families: symptomatic heterogeneity, complement analysis and therapeutic trials. Acta Med Scand. 1972;191:209-219
15. Ohela K. Hereditary angioneurotic oedema in Finland: clinical, immunological and genealogical studies. Acta Med Scand. 1977;201:415-427
16. Zeana C. Hereditary angioedema due to deficit of C1 esterase inhibitor. Med Interne. 1989;27:143-147
17. Nielsen EW, Gran JT, Straume B, Mellbye OJ, Johansen HT, Mollnes TE. Hereditary angio-oedema: new clinical observations and autoimmune screening, complement and kallikreinkinin analyses. J Intern Med. 1996;239:119-130
18. Foix-L'Hélias L, Weiss L, Mollet-Boudjemline A, Fallik D, Trioche-Eberschweiler P, Labrune P. Recurring acute abdominal pains in an adolescent as the presenting manifestations of hereditary angioneurotic oedema. Acta Paediatr. 2005;94:1158-1161
19. Bork K, Hardt J, Schicketanz KH, Ressel N. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch Intern Med. 2003;163:1229-1235
20. El-Hachem C, Amiour M, Guillot M, Laurent J. Hereditary angioneurotic edema: a case report in a 3-year-old child [in French]. Arch Pediatr. 2005;12:1232-1236
21. Bowen T, Cicardi M, Farkas H, et al. Canadian 2003 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema. J Allergy Clin Immunol. 2004;114:629-637
22. Zuraw BL. Diagnosis and management of hereditary angioedema: an American approach. Transfus Apher Sci. 2003;29:239-245
23. Zuraw BL, Sugimoto S, Curd JG. The value of rocket immunoelectrophoresis for C4 activation in the evaluation of patients with angioedema or C1-inhibitor deficiency. J Allergy Clin Immunol. 1986;78:1115-1120
24. Spath PJ, Wütrich B. Inherited and acquired deficiencies of C1 esterase inhibitor in humans. In: Rother K, Till G, Hansch G, eds. The Complement System. Berlin, Germany: Springer; 1998:353-410
25. Davis CA, Vallota EH, Forristal J. Serum complement levels in infancy: age related changes. Pediatr Res. 1979;13:1043-1046
26. Nielsen EW, Johansen HT, Holt J, Mollnes TE. C1 inhibitor and diagnosis of hereditary angioedema in newborns. Pediatr Res. 1994;35:184-187
27. Roach B, Kim Y, Jerome E, Michael AF. Influence of age and sex on serum complement components in children. Am J Dis Child. 1981;135:918-920
28. Kalmár L, Hegedus T, Farkas H, Nagy M, Tordai A. HAEdb: a novel interactive, locus-specific mutation database for the C1 inhibitor gene. Hum Mutat. 2005;25:1-5
29. Kalmár L, Bors A, Farkas H, et al. Mutation screening of the C1 inhibitor gene among Hungarian patients with hereditary angioedema. Hum Mutat. 2003;22:498
30. Farkas H, Varga L. The Hungarian HAE experience. Transfus Apher Sci. 2003;29:229-233
31. Boyle RJ, Nikpour M, Tang ML. Hereditary angio-oedema in children: a management guideline. Pediatr Allergy Immunol. 2005;16:288-294
32. Farkas H, Harmat G, Kaposi PN, et al. Ultrasonography in the diagnosis and monitoring of ascites in acute abdominal attacks of hereditary angioneurotic oedema. Eur J Gastroenterol Hepatol. 2001;13:1225-1230
33. Talavera A, Larraona JL, Ramos JL, et al. Hereditary angioedema: an infrequent cause of abdominal pain with ascites. Am J Gastroenterol. 1995;90:471-474
34. Farkas H, Harmat G, Fekete B, Karadi I, Visy B, Varga L. Acute abdominal attack of hereditary angioneurotic oedema associated with ultrasound abnormalities suggestive of acute hepatitis. Acta Paediatr. 2002;91:971-974
35. Waytes AT, Rosen FS, Frank MM. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. N Engl J Med. 1996;334:1630-1634
36. Gadek JE, Hosea SW, Gelfand JA, et al. Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor. N Engl J Med. 1980;302:542-546
37. Agostoni A, Cicardi M, Bergamaschini L, Boccassini G, Tucci A. C1-inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med. 1980;303:527
38. Bork K, Barnstedt SE. Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Arch Intern Med. 2001;161:714-718
39. Davis AE 3rd. Biological effects of C1 inhibitor. Drug News Perspect. 2004;17:439-446
40. De Serres J, Groner A, Lindner J. Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert P) in hereditary angioedema: a review. Transfus Apher Sci. 2003;29:247-254
41. Frank MM. Hereditary angioedema. Curr Opin Pediatr. 2005;17:686-689
42. Bowen TJ, Zuraw B. Treatment of hereditary angioedema: current USA and Canadian studies. Presented at: meeting of the Network of Rare Blood Disorders Organizations; February 3, 2006; Toronto, Ontario, Canada. Available at: www.hemophilia.ca/nrbdo/pdf/Bowen_Zuraw_Treatment_HAE.ppt. Accessed May 29, 2007
43. Hill BJ, Thomas SH, McCabe C. Fresh frozen plasma for acute exacerbations of hereditary angioedema. Am J Emerg Med. 2004;22:633
44. Pickering RJ, Good RA, Kelly JR, Gewurz H. Replacement therapy in hereditary angioedema: successful treatment of two patients with fresh frozen plasma. Lancet. 1969;1(7590):326-330
45. Lieberman A. The use of fresh-frozen plasma in hereditary angioedema. JAMA. 1994;272:518
46. Farkas H, Fust G, Fekete B, Karadi I, Varga L. Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedema. Lancet. 2001;358:1695-1696
47. Rais M, Unzeitig J, Grant JA. Refractory exacerbations of hereditary angioedema with associated Helicobacter pylori infection. J Allergy Clin Immunol. 1999;103:713-714
48. Bouillet L, Ponard D, Drouet C, Jullien D, Massot C. Angioedema and oral contraception. Dermatology. 2003;206:106-109
49. Agostoni A, Cicardi M. Drug-induced angioedema without urticaria. Drug Saf. 2001;24:599-606
50. Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med. 2006;119:267-274
51. Bork K, Witzke G. Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency. J Allergy Clin Immunol. 1989;83:677-682
52. Abinun M. Hereditary angio-oedema in children. Lancet. 1999;353:2242
53. Gwynn CM. Therapy in hereditary angioneurotic oedema. Arch Dis Child. 1974;49:636-640
54. Ritchie BC. Protease inhibitors in the treatment of hereditary angioedema. Transfus Apher Sci. 2003;29:259-267
55. Farkas H, Harmat G, Gyeney L, Fust G, Varga L. Danazol therapy for hereditary angio-oedema in children. Lancet. 1999;354:1031-1032
56. Barakat A, Castaldo AJ. Hereditary angioedema: danazol therapy in a 5-year-old child. Am J Dis Child. 1993;147:931-932
57. Rajagopal C, Harper JR. Successful use of danazol for hereditary angio-oedema. Arch Dis Child. 1981;56:229-230
58. Gelfand JA, Sherins RJ, Alling DW, Frank MM. Treatment of hereditary angioedema with danazol: reversal of clinical and biochemical abnormalities. N Engl J Med. 1976;295:1444-1448
59. Agostoni A, Cicardi M, Martignoni GC, Bergamaschini L, Marasini B. Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema. J Allergy Clin Immunol. 1980;65:75-79
60. Sheffer AL, Fearon DT, Austen KF. Hereditary angioedema: a decade of management with stanozolol. J Allergy Clin Immunol. 1987;80:855-860
61. Zuraw BL. Current and future therapy for hereditary angioedema. Clin Immunol. 2005;114:10-16
62. Weinblatt ME, Kochen J, Ortega J. Danazol for children with immune thrombocytopenic purpura. Am J Dis Child. 1988;142:1317-1319
63. Cicardi M, Castelli R, Zingale LC, Agostoni A. Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. J Allergy Clin Immunol. 1997;99:194-196
64. Church JA. Oxandrolone treatment of childhood hereditary angioedema. Ann Allergy Asthma Immunol. 2004;92:377-378
65. Maeda S, Miyawaki T, Nomura S, Yagi T, Shimada M. Management of oral surgery in patients with hereditary or acquired angioedemas: review and case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;96:540-543
66. Atkinson JC, Frank MM. Oral manifestations and dental management of patients with hereditary angioedema. J Oral Pathol Med. 1991;20:139-142
67. Farkas H, Gyeney L, Gidofalvy E, Fust G, Varga L. The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures. J Oral Maxillofac Surg. 1999;57:404-408
68. Mohr M, Pollok-Kopp B, Gotze O, Burchardi H. The use of a C1-inhibior concentrate for short-term preoperative prophylaxis in two patients with hereditary angioedema [in German]. Anaesthesist. 1996;45:626-630
69. Socker M, Boyle C, Burke M. Angio-oedema in dentistry: management of two cases using C1 esterase inhibitor. Dent Update. 2005;32:350-352, 354
70. Jaffe CJ, Atkinson JP, Gelfand JA, Frank MM. Hereditary angioedema: the use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery. J Allergy Clin Immunol. 1975;55:386-393
71. Longhurst HJ. Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence? Int J Clin Pract. 2005;59:594-599
72. Farkas H, Harmat G, Fay A, et al. Erythema marginatum preceding an acute oedematous attack of hereditary angioneurotic oedema. Acta Derm Venereol. 2001;81:376-377
73. Széplaki G, Varga L, Valentin S, et al. Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema. J Allergy Clin Immunol. 2005;115:864-869
74. Bork K, Pitton M, Harten P, Koch P. Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema. Lancet. 1999;353:1066-1067
75. Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999;57:1005-1032
76. Snir M, Axer-Siegel R, Buckman G, Yassur Y. Central venous stasis retinopathy following the use of tranexamic acid. Retina. 1990;10:181-184
77. Ritchie BC. Tissue archives to track blood borne pathogens in people receiving blood products. Transfus Apher Sci. 2003;29:269-274
78. Varga L, Széplaki G, Visy B, et al. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema: strong correlation with the severity of disease in C1-INH concentrate naive patients. Mol Immunol. 2007;44:1454-1460
79. Strawczynski H, Stachewitsch A, Morgenstern G, Shaw ME. Delivery of care to hemophilic children: home care versus hospitalization. Pediatrics. 1973;51:986-991
80. Bracho FA. Hereditary angioedema. Curr Opin Hematol. 2005;12:493-498
81. Pappalardo E, Cicardi M, Duponchel C, et al. Frequent de novo mutations and exon deletions in the C1inhibitor gene of patients with angioedema. J Allergy Clin Immunol. 2000;106:1147-1154